Investigational Drug Information for Dasotraline
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the drug development status for Dasotraline?
Dasotraline is an investigational drug.
There have been 12 clinical trials for Dasotraline.
The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2014.
The most common disease conditions in clinical trials are Hyperkinesis, Attention Deficit Disorder with Hyperactivity, and Disease. The leading clinical trial sponsors are Sunovion and [disabled in preview].
There are thirty-nine US patents protecting this investigational drug and three hundred and thirty-one international patents.
Summary for Dasotraline
| US Patents | 39 |
| International Patents | 331 |
| US Patent Applications | 127 |
| WIPO Patent Applications | 53 |
| Japanese Patent Applications | 30 |
| Clinical Trial Progress | Phase 3 (2014-06-01) |
| Vendors | 21 |
Recent Clinical Trials for Dasotraline
| Title | Sponsor | Phase |
|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting. | Sunovion | Phase 3 |
| A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder | Sunovion | Phase 3 |
| Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction | Sunovion | Phase 1 |
Clinical Trial Summary for Dasotraline
Top disease conditions for Dasotraline
Top clinical trial sponsors for Dasotraline
US Patents for Dasotraline
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Dasotraline | See Plans and Pricing | Preparation of chiral amides and amines | SUNOVION PHARMACEUTICALS INC. (Marlborough, MA) | See Plans and Pricing |
| Dasotraline | See Plans and Pricing | Dosage of dasotraline and method for treatment of ADHD | SUNOVION PHARMACEUTICALS INC. (Marlborough, MA) | See Plans and Pricing |
| Dasotraline | See Plans and Pricing | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | See Plans and Pricing |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Dasotraline
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Dasotraline | Australia | AU2007233041 | 2026-03-31 | See Plans and Pricing |
| Dasotraline | Canada | CA2648121 | 2026-03-31 | See Plans and Pricing |
| Dasotraline | China | CN101421228 | 2026-03-31 | See Plans and Pricing |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
